Plus Therapeutics SG&A Expense (TTM) Trends

Plus Therapeutics Inc (PSTV)

1.85 +0.31 (+20.13%) USD | NASDAQ | Sep 27, 16:00

1.80 -0.05 (-2.70%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2003. Upgrade now.

Date	Value
June 30, 2024	8.793M
March 31, 2024	8.514M
December 31, 2023	8.546M
September 30, 2023	9.752M
June 30, 2023	9.976M
March 31, 2023	10.34M
December 31, 2022	10.24M
September 30, 2022	8.694M
June 30, 2022	8.462M
March 31, 2022	7.642M
December 31, 2021	6.853M
September 30, 2021	7.11M
June 30, 2021	6.18M
March 31, 2021	6.14M
December 31, 2020	6.406M
September 30, 2020	5.779M
June 30, 2020	5.889M
March 31, 2020	5.432M
December 31, 2019	5.291M
September 30, 2019	4.606M
June 30, 2019	4.891M
March 31, 2019	5.913M
December 31, 2018	7.358M
September 30, 2018	8.503M
June 30, 2018	9.673M

Date	Value
March 31, 2018	11.06M
December 31, 2017	11.19M
September 30, 2017	11.86M
June 30, 2017	12.07M
March 31, 2017	11.90M
December 31, 2016	12.18M
September 30, 2016	12.07M
June 30, 2016	12.18M
March 31, 2016	12.41M
December 31, 2015	12.43M
September 30, 2015	13.63M
June 30, 2015	16.34M
March 31, 2015	19.43M
December 31, 2014	22.36M
September 30, 2014	24.83M
June 30, 2014	25.30M
March 31, 2014	25.22M
December 31, 2013	25.06M
September 30, 2013	24.94M
June 30, 2013	25.05M
March 31, 2013	24.96M
December 31, 2012	25.16M
September 30, 2012	25.39M
June 30, 2012	26.32M
March 31, 2012	27.82M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

4.606M

Minimum

Sep 2019

10.34M

Maximum

Mar 2023

7.532M

Average

7.376M

Median

SG&A Expense (TTM) Benchmarks